SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-072786
Filing Date
2018-03-07
Accepted
2018-03-07 07:30:56
Documents
5
Period of Report
2018-03-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d454697d8k.htm 8-K 16596
2 EX-23.1 d454697dex231.htm EX-23.1 1770
3 EX-99.1 d454697dex991.htm EX-99.1 22068
4 EX-99.2 d454697dex992.htm EX-99.2 224350
5 GRAPHIC g454697g33b69.jpg GRAPHIC 4414
  Complete submission text file 0001193125-18-072786.txt   272257
Mailing Address 430 EAST 29TH STREET SUITE 1040 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET SUITE 1040 NEW YORK NY 10016 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36829 | Film No.: 18671896
SIC: 2834 Pharmaceutical Preparations